Publications Database

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Anagnostou E. et al.

Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial.

JAMA Psychiatry

Read Abstract (New Window)

Canitano R. (2005)

Clinical experience with topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders.

Brain and Development

27(3), pp, 228-232

Read Abstract (New Window)

Canitano R. , Scandurra V. (2008)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents.

Neuropsychiatric Disease and Treatment

4(4), pp. 723-730

Read Abstract (New Window) Read Full (New Window)

Capone G. et al. (2008)

Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: A naturalistic study.

Journal of Developmental and Behavioral Pediatrics

29(2), pp. 106-116

Read Abstract (New Window)

Chavez B. et al. (2007)

Atypical antipsychotics in children with pervasive developmental disorders.

Pediatric Drugs

9(4), pp. 249-266

Read Abstract (New Window)

Cohen D. et al. (2013)

Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects.

Research in Autism Spectrum Disorders

7(1), pp. 167-175.

Read Abstract (New Window)

Cohen S. . A. et al. (2004)

The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment.

Journal of Clinical Psychiatry

65(1), pp. 110-113

Read Abstract (New Window)

Coskun M. et al. (2009)

Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

19(2), pp. :203-206

Read Abstract (New Window)

Eaves L. C. , Ho H. H. (2008)

Young adult outcome of autism spectrum disorders.

Journal of Autism and Developmental Disorders

April, 38(4), pp. 739-747

Read Abstract (New Window)

Fedorow V. , Fombonne E. (2005)

Metabolic side effects of atypical antipsychotics in children: a literature review.

Journal of Psychopharmacology

19(5), pp. 533-550

Read Abstract (New Window)

Findling R. L. , Maxwell K. , Wiznitzer M. (1997)

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

Psychopharmacology Bulletin

33(1), pp. 155-159

Read Abstract (New Window)

Gagliano A. et al. (2004)

Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 39-47

Read Abstract (New Window)

Gencer O. et al. (2008)

Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder : An open label maintenance study.

European Child and Adolescent Psychiatry

17(4), pp. 217-225

Read Abstract (New Window)

Gonzalez N. M. et al. (1994)

Naltrexone plasma levels, clinical response and effect on weight in autistic children.

Psychopharmacology Bulletin

30(2), pp. 203-208

Read Abstract (New Window)

Hellings J. A. et al. (2006)

A crossover study of risperidone in children, adolescents and adults with mental retardation.

Journal of Autism and Developmental Disorders

36(3), pp. 401-411

Read Abstract (New Window)

Hellings J. A. et al. (2001)

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.

Journal of Child and Adolescent Psychopharmacology

11(3), pp. 229-238

Read Abstract (New Window)

Hollander E. et al. (2006)

A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder

Journal of Child and Adolescent Psychopharmacology

16 pp. 541-548

Read Abstract (New Window)

Horrigan J. , Barnhill L. (1997)

Risperidone and explosive aggressive autism.

Journal of Autism and Developmental Disorders

27(3), pp. 313-323

Read Abstract (New Window)

Hsu C. et al. (2009)

The effects of a gluten and casein-free diet in children with autism: A case report.

Chang Gung Medical Journal

32(4), pp. 459-465

Read Abstract (New Window) Read Full (New Window)